SeraCare Life Sciences Inc announced that the company has launched a set of new products in its diagnostic controls and panels portfoliothe SeraCare HIV-1 Seroconversion Panels.
Read MoreBD Diagnostics announced that it has received “Moderate Complexity” status from the FDA, under the Clinical Laboratory Improvement Amendments (CLIA), for the BD MAX GBS Assay for Group B Streptococcus(GBS).
Read More
Increased demand for testing, new technologies and emerging markets have trumped the economic situation in the world in vitro diagnostics (IVD) market, according a new Kalorama Information report.
Read MoreCLSI unveiled the release of StatisPro, its new method evaluation software package for the evaluation, verification, and validation of performance characteristics of laboratory test methods.
Read More